188 related articles for article (PubMed ID: 3920548)
1. Time-dependent interaction between phenytoin and valproic acid.
Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
[TBL] [Abstract][Full Text] [Related]
2. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
3. Phenytoin--valproic acid interaction in rhesus monkey.
Koch KM; Ludwick BT; Levy RH
Epilepsia; 1981 Feb; 22(1):19-25. PubMed ID: 6781887
[TBL] [Abstract][Full Text] [Related]
4. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
Haidukewych D; Rodin EA; Zielinski JJ
Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
[TBL] [Abstract][Full Text] [Related]
5. Valproate metabolites in high-dose valproate plus phenytoin therapy.
Sugimoto T; Muro H; Woo M; Nishida N; Murakami K
Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852
[TBL] [Abstract][Full Text] [Related]
6. Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients.
Riva R; Albani F; Cortelli P; Gobbi G; Perucca E; Baruzzi A
Ther Drug Monit; 1983 Jun; 5(2):191-6. PubMed ID: 6410545
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of valproate coadministration and hypoalbuminemia on the serum-free phenytoin concentration in patients with severe motor and intellectual disabilities.
Mamiya K; Yukawa E; Matsumoto T; Aita C; Goto S
Clin Neuropharmacol; 2002; 25(4):230-3. PubMed ID: 12151911
[TBL] [Abstract][Full Text] [Related]
8. Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding.
Tasaki K; Minami T; Ieiri I; Ohtsubo K; Hirakawa Y; Ueda K; Higuchi S
Brain Dev; 1995; 17(3):182-5. PubMed ID: 7573757
[TBL] [Abstract][Full Text] [Related]
9. Chronic valproic acid therapy and incidence of increases in venous plasma ammonia.
Haidukewych D; John G; Zielinski JJ; Rodin EA
Ther Drug Monit; 1985; 7(3):290-4. PubMed ID: 3931312
[TBL] [Abstract][Full Text] [Related]
10. Diurnal oscillations in plasma protein binding of valproic acid.
Patel IH; Venkataramanan R; Levy RH; Viswanathan CT; Ojemann LM
Epilepsia; 1982 Jun; 23(3):283-90. PubMed ID: 6806086
[TBL] [Abstract][Full Text] [Related]
11. Monitoring free valproic acid in epilepsy patients medicated with coanticonvulsants.
Haidukewych D; Rodin EA
Ther Drug Monit; 1982; 4(2):209-12. PubMed ID: 6808716
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
de Wolff FA; Peters AC; van Kempen GM
Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
[TBL] [Abstract][Full Text] [Related]
13. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
Steinborn B; Galas-Zgorzalewicz B
Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
Irshaid YM; Hamdi AA; Al Homrany M
Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid-phenytoin interaction.
Friel PN; Leal KW; Wilensky AJ
Ther Drug Monit; 1979; 1(2):243-8. PubMed ID: 122160
[TBL] [Abstract][Full Text] [Related]
16. Comparison of total and free phenytoin serum concentrations measured by high-performance liquid chromatography and standard TDx assay: implications for the prediction of free phenytoin serum concentrations.
May TW; Rambeck B; Jürges U; Blankenhorn V; Jürgens U
Ther Drug Monit; 1998 Dec; 20(6):619-23. PubMed ID: 9853976
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
May TW; Rambeck B; Nothbaum N
Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
[TBL] [Abstract][Full Text] [Related]
18. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
Della Paschoa OE; Voskuyl RA; Danhof M
Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091
[TBL] [Abstract][Full Text] [Related]
19. Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.
Gatti G; Crema F; Attardo-Parrinello G; Fratino P; Aguzzi F; Perucca E
Ther Drug Monit; 1987 Dec; 9(4):389-91. PubMed ID: 3122377
[TBL] [Abstract][Full Text] [Related]
20. Prediction of free levels of phenytoin and carbamazepine in patients comedicated with valproic acid.
Ratnaraj N; Hjelm M
Ther Drug Monit; 1995 Aug; 17(4):327-32. PubMed ID: 7482684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
